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Objective: To describe a method to reduce the external
radiation exposure emitted from the patient after liver-
directed radioembolization using 90Y glass microspheres,
to quantitatively estimate the occupational dose of
medical personnel providing patient care to the patient
radioembolized with the use of the method and to
discuss radiation exposure to patients who are adjacent
if the patient radioembolized needs hospitalization.
Methods: A lead-lined blanket of lead equivalence of
0.5mm was used to cover the patient abdomen immedi-
ately after the 90Y radioembolization procedure, in order to
reduce the radiation emitted from the patient. The interven-
tional radiologist used a rod-type puncture site compressor
for haemostasis to avoid direct contact with possible
residual radioactivity at the puncture site. Dose rates were
measured at the interventional radiologist chest and hand
positions during puncture site pressing for haemostasis with
andwithout the use of the blanket. Themeasurement results
were applied to estimate the occupational dose of col-
leagues performing patient care to the patient radioembol-
ized. The exposure to patients adjacent in the ward was
estimated if the patient radioembolized was hospitalized.
Results: The radiation exposures measured at the radiol-
ogist chest and hand positions have been significantly
reduced with the lead-lined blanket in place. The
radiologist, performing puncture site pressing at the end
of radioembolization procedure, would receive an aver-
age hand dose of 1.95mSv and body dose under his own
lead apron of 0.30mSv for an average 90Y microsphere
radioactivity of 2.54GBq. Other medical personnel,
nurses and porters, would receive occupational doses
corresponding to an hour of background radiation. If the
patient radioembolized using 90Y needs hospitalization in
a common ward, using the lead-lined blanket to cover the
abdomen of the patient and keeping a distance of 2m
from the patient who is adjacent would reduce the
exposure by 0.42% of dose limit for the general public.
Conclusion: By placing a lead-lined blanket on the patient
abdominal region after 90Y radioembolization, hospital
staff receive minimal radiation exposure in order to
comply with the radiation protection “as low as reason-
ably achievable” principle. There will be no increase in
radiation level in ward if the patient radioembolized using
90Y needs to be hospitalized. Therefore, the patient
radioembolized can be accommodated alternatively at
a corner bed of a common ward if an isolation room with
private toilet facility is not available.
Advances in knowledge: To reduce exposure to person-
nel providing patient care to patients radioembolized
using 90Y.
INTRODUCTION
90Y microsphere radioembolization is an emerging mo-
dality for the treatment of liver malignancies.1,2 Radio-
embolization involves placing radioactive microspheres,
tiny 90Y-coated resin or glass beads,3,4 directly at the tu-
mour via the interventional radiology technique. It is based
on the unique pattern of hepatic blood flow by which the
majority of the tumour blood supply is derived from the
hepatic artery, whereas hepatic parenchymal blood flow
largely comes from the portal vein. When 90Y microspheres
are introduced through the hepatic artery with the use of
a catheter, 90Y microspheres will preferentially localize in
the peritumoral and intratumoral arterial vasculature, de-
livering a high dose of radiation to the tumours.1,2 At the
completion of the radioembolization procedure, the cath-
eter is removed and the patient is returned to the ward for
observation before discharge.3,4 The existing radiation
protection measures in 90Y microsphere radioembolization
include the use of low atomic number materials of acrylic or
plastic in 90Y microsphere dose preparation and administration
as well as a radiation survey to personnel and areas after each
administration. Proper waste storage and disposal of radioactive
items should also be performed according to local radiation
usage guidelines.
With better understanding of the treatment dosimetry,5,6 there is
a trend to administer higher 90Y radioactivity for better patient
efficacy.7 This raises a concern about the occupational radiation
dose received by medical personnel caring for patients who
undergo radioembolization,8 particularly for interventional
radiologists performing puncture site pressing for haemostasis
because the radiologist stands close to the patients treated using
90Y. If the patient is hospitalized after the 90Y radioembolization,
further concern about the radiation safety to patients adjacent in
a common ward has to be addressed. Although there are local
guidelines and regulations regarding the safe use of radioisotopes
in hospitals, further measures to reduce radiation dose to staff
and to patients who are adjacent are useful in order to comply
with the “as low as reasonably achievable” principle.9
90Y is a pure b-emitting radioisotope of an average energy of
0.94MeV with a maximum radiation range of 11mm in the
tissue and physical half-life of 64 h. Following treatment with 90Y
microspheres, the patient becomes a source of radiation that
could potentially affect other persons via bremsstrahlung
emission as a result of 90Y b-particles interacting with the sur-
rounding body tissues in vivo.10 The production of in vivo
bremsstrahlung of 90Y microspheres is sufficient in external
detection and imaging.1,2 Therefore, the resulting external ra-
diation hazard to interventional suite personnel has to be eval-
uated and minimized immediately after the patient
radioembolization procedure.
In this article, we describe the use of a lead-lined blanket to
cover the patient abdomen to reduce the bremsstrahlung radi-
ation emitted from patients treated using 90Y. A rod-type
puncture site compressor for haemostasis was also used by the
interventional radiologist to avoid direct contact with possible
residual radioactivity at the puncture site. The radiologist was
dressed in a lead apron of lead equivalence of 0.5mm during
puncture site pressing. Dose rates at the radiologist hands and at
chest position in front of his lead apron were measured during
the puncture site pressing after radioembolization with and
without the use of the lead-lined blanket.
METHODS AND MATERIALS
Since mid-2014, there have been 18 patients treated with 90Y
glass microspheres for hepatocellular carcinoma in our in-
stitution. 16 (89%) of them are males of an average age of 646
9 years (range: 46–80 years), and the remaining 2 (11%) them
are females of an average age of 75 years (range: 44–83 years).
The average administered radioactivity for 90Y glass micro-
spheres (18 patients, 18 administrations) was 2.546 0.87GBq
(range: 1.65–4.75GBq).
A lead-lined blanket of size 603 64 cm, weight about 4 kg and
lead equivalence of 0.5mm has been used in the study.
The blanket was wrapped in a sterilized plastic bag and was
placed on the patient abdominal region immediately after the
90Y microsphere radioembolization procedure. All patients were
tolerated to the size and weight of the blanket.
Figure 1 shows the interventional radiologist performing
puncture site pressing for haemostasis with the use of the rod-
type compressor and the lead-lined blanket placed on the ab-
domen of the patient radioembolized. At each patient admin-
istration session, radiation dose rates at the chest position
(approximately 0.5m from the patient abdomen) and at the
hand position (approximately 10 cm above the puncture site) of
the interventional radiologist were measured with a calibrated
radiation survey meter (model 451; Fluke, Cleveland, OH) with
and without the blanket in place. These measured dose rates
were then normalized by the patient-administered 90Y micro-
sphere radioactivity. After performing the same normalization
for a number of patient administrations, normalized average
dose rates, expressed as average dose rate per unit radioactivity
of the 90Y microsphere administered, were obtained at the
interventional radiologist hand and body chest. The normalized
average body dose rate was then used to estimate the occupa-
tional dose of nurse and porter colleagues who provided patent
care to the patient radioembolized during patient transfer from
the X-ray table to the patient stretcher and during patient
transport from the interventional suite back to the patient ward,
respectively, by knowing their average time spent with the pa-
tient radioembolized and the patient-administered 90Y micro-
sphere radioactivity. From the experience of our nurse and
porter colleagues working in the interventional suite, it takes not
more than 5min for our nurse colleagues to transfer the patient
radioembolized from the X-ray table to the patient stretcher.
Similarly, it takes not more than 15min for our porter colleagues
to transport the patient radioembolized from the interventional
suite back to the patient ward in our institution.
Figure 1. After the radioembolization procedure, a lead-lined
blanket is covered over the patient abdomen. The interven-
tional radiologist uses a rod-type compressor for puncture site
compression for haemostasis. The radiologist wears a lead
apron of the same lead equivalence of 0.5 mm as the blanket.
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The same normalization method was also used to estimate the
radiation dose received by patients who are adjacent in a com-
mon ward with the abdomen of the patient radioembolized
covered with the lead-lined blanket during hospitalization.
Statistical method
The t-test for paired samples was used to compare the difference
in the measured dose rates between using the lead-lined blanket
or not. The software used was SAS (v. 9.4, Cary, NC). Values of
p# 0.05 were considered to be statistically significant.
RESULTS
Table 1 shows the dose rates, normalized by the patient-
administered 90Y microsphere radioactivity, measured at the
chest position of the interventional radiologist and at the hand
position during puncture site pressing with and without the
lead-lined blanket covering the patient abdominal region.
Without the use of the blanket, the normalized average dose rate
at the radiologist body position was measured as 1.436
0.31mSv/(hGBq). With the use of the blanket, the normalized
average dose rate at the radiologist body position was measured
as 0.716 0.16mSv/(hGBq). Therefore, an average dose rate re-
duction factor of 0.50 at the radiologist body position was
obtained with the use of the blanket. Similarly, an average dose
rate reduction factor of 0.38 at the radiologist hand position was
obtained with the use of the blanket (Table 1). Dose rate reduc-
tions to the radiologist body and hand were statistically significant
when the lead-lined blanket was used (p, 0.01). At the radiol-
ogist hand position during puncture site pressing, the normalized
average dose rate was measured as 2.30mSv/(hGBq). The average
infused 90Y radioactivity among our patients was 2.54GBq. The
radiologist thus received 1.95mSv at his hands during puncture
site pressing for an average of 20min of pressing time for each 90Y
radioembolization administration. Similarly, the normalized dose
rate at the radiologist body position was measured as 0.71mSv/
(hGBq), corresponding to an average dose of 0.60mSv.
Since the radiologist also wears a lead apron of the same lead
equivalence of 0.5mm of the lead-lined blanket, he would ac-
tually receive a body dose of 0.30mSv (by the same dose re-
duction factor of 0.50 with the use of the blanket) under his own
lead apron. This average 0.30mSv occupational dose is compa-
rable with the 1 hour background radiation level at our
institution area.
The radiation dose measurement at the radiologist chest
position of 0.71mSv/(h GBq) at 0.5m from the patient
radioembolized using 90Y can be used to estimate the occu-
pational dose of nurse and porter colleagues who perform
patient transfer from the X-ray table to the patient stretcher
and patient transport from the interventional suite back to the
patient ward, respectively, after the 90Y radioembolization
procedure. The distance of 0.5m between the patient radio-
embolized and nurse and porter colleagues has been consid-
ered in the occupational dose calculation for these colleagues
to take into account possible close contact with the patient
during their patient care. The calculated occupational expo-
sures to the supporting team colleagues, 0.15mSv for the nurse
and 0.45mSv for the porter, are therefore regarded as an upper
bound and are indeed very minimal during the course of the
care of the patient radioembolized (Table 2). In comparison,
the daily background radiation level is about 6mSv in our in-
stitution area.
Our patient service in using 90Y microsphere radio-
embolization has been about 10 cases per year. With this
workload, the radiologist would receive an annual dose of
3mSv as a whole-body dose and 19.50mSv as a hand dose
with the use of the lead-lined blanket during puncture site
pressing after each radioembolization procedure. The annual
dose limits for an occupational radiation worker, as recom-
mended by the International Commission on Radiological
Protection (ICRP), are 20mSv for the whole body and
500mSv for the skin averaged over any 1 cm2 area of an
extremity.9 Therefore, the occupational doses received by the
radiologist and other supporting team colleagues, as dis-
cussed in the present study, are far below the dose limits as
recommended by ICRP.9
DISCUSSION
Radiation safety considerations in 90Y radioembolization have
been described in detail for patient dosimetry accuracy,5,6
interventional radiology suite radiation contamination pre-
vention and scenarios for patients radioembolized who come
in contact with their family.10,11 In our present work using
a lead-lined blanket of 0.5mm lead equivalence with size and
weight tolerable to patient comfort, it has been shown that
bremsstrahlung radiation emitted from the patient treated
using 90Y can be significantly shielded, resulting in less expo-
sure to the interventional suite personnel. This dose reduction
is useful in maintaining a low occupational dose to personnel
according to the “as low as reasonably achievable” principle
and to cope with the trend of administering higher 90Y
radioactivity in radiation protection and safety.7
Table 1. Normalized average dose rates (mean6 standard deviation) of the interventional radiologist performing puncture site
pressing with and without the use of blanket
Use of lead-lined blanket
Normalized average dose rate [mSv/(hGBq)]
Radiologist body dose Radiologist hand dose
No (n5 18) 1.436 0.31 (range: 1.09–2.21) 6.056 2.84 (range: 2.41–14.55)
Yes (n5 18) 0.716 0.16 (range: 0.43–1.10) 2.306 0.99 (range: 0.97–4.55)
p-value ,0.01 ,0.01
There were 18 patient measurements (n5 18).
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Generally, there are local recommendations and regulations re-
garding the safe use of unsealed radioactive substance to patients
during hospitalization and to patient release. Our institutional
radiation safety regulation requires that patients treated using
90Y of .1.5 GBq radioactivity be accommodated in a single
room ideally with private toilet facility.12 Sometimes, this cannot
be achieved owing to insufficient isolation ward availability or
non-availability of such a facility in some hospitals; but, 90Y
radioembolization has to be performed. We suggest that the
patient treated using 90Y be accommodated at a corner bed in
a common ward with the use of the lead-lined blanket. The
normalized average dose rate at 0.5 m from the patient radi-
oembolized has been measured as 0.71mSv/(h GBq), corre-
sponding to 1.80mSv/h for an average 2.54 GBq 90Y
microsphere radioactivity. The distance maintained between
patients who are adjacent in a common ward is normally
about 2m. The radiation dose rate at the patient who is ad-
jacent is calculated as 0.11mSv/h using the inverse square law.
The patient radioembolized is suggested to stay at the corner
bed for the next 49 h until the 90Y radioactivity has physically
decayed from 2.54 to 1.5 GBq before release from hospitali-
zation. Since the initial dose rate at the patient who is adja-
cent is 0.11mSv/h, the patient would receive a total dose of
4.20mSv during the 49-h hospitalization period of the patient
radioembolized. The dose limit for the general public is 1 mSv
per year, as recommended by ICRP.9 Therefore, a radiation
dose of 4.20mSv received by the patient who is adjacent
corresponds to 0.42% of the annual dose limit for the general
public and is considered as negligible. On the other hand, if
the patient treated using 90Y stays at the corner bed without
the use of the lead-lined blanket, the patient adjacent would
receive a dose of 8.4mSv (the dose reduction factor of the
blanket being 0.5 for body dose) for the same scenario just
discussed. A radiation dose of 8.4mSv is slightly higher than
the daily background radiation level in our institution area
(about 6mSv). In other words, radiation exposure to the
patient adjacent due to the patient treated using 90Y is low
and can be further reduced to a negligible level if the use of
a lead-lined blanket and a distance of 2 m between patients
who are adjacent are followed.
Therefore, with the use of the lead-lined blanket for the patient
radioembolized, hospital resource in isolation room facility and
radiation exposure to other patients who are adjacent and non-
radioactive may no longer be of concern while performing 90Y
radioembolization.
CONCLUSION
A practical measure of using a lead-lined blanket not only
reduces the occupational dose of the interventional suite per-
sonnel to the background level, but also solves the problem of
limited isolation room availability. A rod-type puncture site
compressor for haemostasis is used by the interventional radi-
ologist to avoid direct contact with possible residual radioactivity
at the puncture site. The present work is applicable to both types
of 90Y microspheres of resin and glass.3,4
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